Subjects' expectations in neuroimaging research

被引:79
作者
Kirschen, MP
Jaworska, A
Illes, J
机构
[1] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Radiol, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Program Neurosci, Stanford, CA USA
[4] Stanford Univ, Dept Philosophy, Stanford, CA 94305 USA
关键词
incidental findings; neuroethics; neuroimaging; fMRI; informed consent; therapeutic misconception;
D O I
10.1002/jmri.20499
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To explore subjects' attitudes and expectations concerning the detection and management of incidental findings in neuroimaging research. Materials and Methods: Healthy control subjects (N = 105) who previously participated in neuroinraging studies in medical and nonmedical settings were surveyed about their expectations and attitudes toward unexpected clinical findings on their research brain scans. We hypothesized that even though the participants consented to a scanning procedure for research purposes alone, they would still expect pathology, if present, to be detected and reported to them. Results: Fifty-four percent of participants reported that they expected research scans to detect abnormalities if they existed. Nearly all subjects (> 90%) reported that they would want findings communicated to them, and many (59%) preferred this to be done by a physician affiliated with the research team. The participants responded in similar ways whether they were scanned in medical or nonmedical settings. Conclusion: Clarity about procedures for handling incidental findings when obtaining written and verbal informed consent is essential to ensure that the subjects' expectations are consistent with the purpose and scope of the research.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 36 条
[1]  
Appelbaum Paul S., 2002, American Journal of Bioethics, V2, P22, DOI 10.1162/152651602317533596
[2]   FALSE HOPES AND BEST DATA - CONSENT TO RESEARCH AND THE THERAPEUTIC MISCONCEPTION [J].
APPELBAUM, PS ;
ROTH, LH ;
LIDZ, CW ;
BENSON, P ;
WINSLADE, W .
HASTINGS CENTER REPORT, 1987, 17 (02) :20-24
[3]  
Barnes JA, 1999, CELL STRESS CHAPERON, V4, P250, DOI 10.1379/1466-1268(1999)004<0250:EOGRPG>2.3.CO
[4]  
2
[5]  
Brainard Jeffrey, 2003, Chron High Educ, V49, pA21
[6]   Impact of quality of life on patient expectations regarding phase I clinical trials [J].
Cheng, JD ;
Hitt, J ;
Koczwara, B ;
Schulman, KA ;
Burnett, CB ;
Gaskin, DJ ;
Rowland, JH ;
Meropol, NJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :421-428
[7]   PERCEPTIONS OF CANCER-PATIENTS AND THEIR PHYSICIANS INVOLVED IN PHASE-I TRIALS [J].
DAUGHERTY, C ;
RATAIN, MJ ;
GROCHOWSKI, E ;
STOCKING, C ;
KODISH, E ;
MICK, R ;
SIEGLER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1062-1072
[8]   Informed consent for clinical trials: a comparative study of standard versus simplified forms [J].
Davis, TC ;
Holcombe, RF ;
Berkel, HJ ;
Pramanik, S ;
Divers, SG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) :668-674
[9]   Interventions to improve research participants' understanding in informed consent for research - A systematic review [J].
Flory, J ;
Emanuel, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (13) :1593-1601
[10]  
Fried E, 2001, Account Res, V8, P331, DOI 10.1080/08989620108573984